Breast cancer susceptibility gene

Breast cancer is the most common cancer among women, and the second leading cause of mortality from cancer. The American Cancer Society estimates that in the US this year, over 182,000 women have been newly diagnosed with invasive breast cancer. Mutations in the so-called breast cancer susceptibility gene, BRCA1, account for 40-50% of early onset familial breast cancer cases and >75% of familial breast/ovarian cancer cases. Recently, scientists have discovered that the protein ATR is responsible for activating BRCA1 in response to UV light-induced DNA damage. As published in Genes & Development, this discovery provides the first evidence that ATR may be the newest breast cancer susceptibility gene.

Our genomes are under frequent attack by environmental carcinogens, metabolic byproducts and spontaneous mutations. On a daily basis we are exposed to UV light, which can introduce covalent bonds between adjacent bases in DNA, thereby altering the normal double-helical shape of DNA and blocking its replication. Whether or not this DNA damage is repaired properly is a primary determinant in the development of cancer. DNA damage repair involves a cascade of phosphorylating enzymes, or kinases, which regulate the action of specific repair proteins. BRCA1 is believed to be one of these repair proteins. In cells that have lost BRCA1 function, there are increased rates of mutation in response to DNA damage, and therefore a greater susceptibility to cancer.

Dr. Abraham and colleagues have discovered that after cells are exposed to UV light, the kinase ATR phosphorylates BRCA1 at six different sites. By up-regulating or down-regulating ATR expression levels, Dr. Abraham and colleagues were able to observe that BRCA1 phosphorylation increases or decreases, respectively. Phosphorylated BRCA1 relocalizes to distinct sites of DNA damage within the cell nucleus, and presumably aids in their repair. In addition to more clearly delineating the pathway of BRCA1 respo

Contact: Nora Poppito
Cold Spring Harbor Laboratory

Page: 1 2

Related biology news :

1. Breast cancer patients failed by treatment with taxol and taxotere respond to abraxane
2. Breastfeeding decreases infant mortality
3. Breast cancer study suggests role for tissue in carcinogenesis
4. Breast self examination increases womens concerns but has no effect on mortality
5. Breast cancer follow-ups no longer guess-work thanks to new physics research
6. Final media advisory for the 4th European Breast Cancer Conference (EBCC-4)
7. The 4th European Breast Cancer Conference (EBCC4)
8. Breast cancer susceptibility genes play role in DNA repair
9. Breast cancer can be reversed in laboratory mice, scientists report
10. NIH funds Breast Cancer and the Environmental Research Center at Fox Chase Cancer Center
11. Breast fluid a better option for detecting cancer

Post Your Comments:

(Date:8/19/2019)... ... August 19, 2019 , ... Since ... use of ultra-thin two dimensional slices which are placed on microscope slides, stained ... complex tissues and complicated features such as vasculature and thus researchers in the ...
(Date:8/15/2019)... ... ... Deep Science Ventures (DSV), a new paradigm for applied science, today announced ... 100 companies over the next 10 years to address the urgent need for new ... was founded to create a better method for launching science companies; one that takes ...
(Date:8/15/2019)... ... , ... Serialization deadlines in the US and European Union ... becomes fully applied in the United States in 2023, pharmaceutical companies are scrutinizing ... most regulations?including the Drug Supply Chain Security Act (DSCSA)?have required minimal system capabilities. ...
Breaking Biology News(10 mins):
(Date:8/15/2019)... ... August 15, 2019 , ... PathSensors announced today that Roger ... of the Institute of Food Technologists (IFT) Board of Directors, Illinois Institute of ... for Food Safety and Applied Nutrition (JIFSAN) Advisory Council and the University of ...
(Date:8/14/2019)... STATE COLLEGE, Pa. (PRWEB) , ... August 13, ... ... leader in nuclear receptor and in vitro toxicology testing solutions, announced the appointment ... of healthcare industry experience to the Board. , Mark McLoughlin will lend his ...
(Date:8/14/2019)... ... August 13, 2019 , ... ... prepackaged mobile phases for QC laboratories. After gaining a few significant clients, Lifecycle ... approach into a valued supplier of manufacturing processing solutions, including reagents for tissue ...
(Date:8/8/2019)... , ... August 08, 2019 , ... ... Agents for sales and service organizations, today announced that the company’s Studio ... Award for the IVA market . Inference will officially accept the award at ...
Breaking Biology Technology:
Cached News: